Denosumab salvage therapy in a 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery

Elsevier

Available online 23 February 2023, 101427

NeurochirurgieAuthor links open overlay panel, , , , , Abstract

Giant cell tumors (GCTs) of the bone are locally aggressive primary bone tumors with a benign character. Spinal involvement is rare which accounts for approximately 5% of all primary bone tumors and it is quite rare in the lumbar spine. A 11-year-old boy patient presented with pain of low back and bilateral low extremities. Lumbar CT and MRI revealed a lytic lesion of the L4 vertebra corpus. The patient earned remarkable and timely recovery with 2 surgical interventions and the use of denosumab. Surgical resection for GCTs is still preferable as the initial treatment, denosumab should be utilized after tumor resection whether based on the purpose of prevention or treatment of tumor recurrence.

Keywords

Giant cell tumor (GCT)

denosumab

fusion

case report

spine

© 2023 The Authors. Published by Elsevier Masson SAS.

留言 (0)

沒有登入
gif